Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Infections × Anidulafungin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1 Infections 1

Interventions

plerixafor 2 Voriconazole 2 Levofloxacin 2 threonic acid 1 amphotericin B, deoxycholate drug combination 1 Polymerase Chain Reaction 1 Nystatin 1 Magnesium Sulfate 1 Interferon-gamma 1 Immunoenzyme Techniques 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 ER 30346 1 Cone-Beam Computed Tomography 1 Cefepime 1 Caspofungin 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Bevacizumab 1 Anidulafungin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00068471 2013-06-19

Anidulafungin in Treating Immunocompromised Children With Neutropenia

National Cancer Institute (NCI)

Phase 1/2 Completed

Infections, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡